Cited by 261Liver physiology and pathologyDrug Transport and Resistance MechanismsNuclear Receptors and Signaling

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Nuclear Receptors in Liver Disease Δ

Open access

Wagner, Martin, Zollner, Gernot, Trauner, Michael·2011·Hepatology

Open this paper in CoChat — free account Open PDF

Abstract

Nuclear receptors are ligand-activated transcriptional regulators of several key aspects of hepatic physiology and pathophysiology. As such, nuclear receptors control a large variety of metabolic processes including hepatic lipid metabolism, drug disposition, bile acid homeostasis, as well as liver regeneration, inflammation, fibrosis, cell differentiation, and tumor formation. Derangements of nuclear receptor regulation and genetic variants may contribute to the pathogenesis and progression of liver diseases. This places nuclear receptors into the frontline for novel therapeutic approaches for a broad range of hepatic disorders and diseases including cholestatic and fatty liver disease, drug hepatotoxicity, viral hepatitis, liver fibrosis, and cancer. (Hepatology 2011;.)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.24148

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Principles for modulation of the nuclear receptor superfamily
Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,285
Nuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 318
Nuclear receptors: Decoding metabolic disease
Sonoda, J., Pei, L., & Evans, R. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.016 · Cited by 313
Nuclear receptor regulation of hepatic function
Karpen, S. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00129-0 · Cited by 173
Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases
Arrese, M., & Karpen, S. J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.2 · Cited by 54

Flagged first, then by citations

Show all 7 references

Sorted by citations

Items 201–261 of 261

New Approach Methods for Hazard Identification: A Case Study with Azole Fungicides Affecting Molecular Targets Associated with the Adverse Outcome Pathway for Cholestasis
Knebel, C., Süßmuth, R. D., Hammer, H., Braeuning, A., & Marx‐Stoelting, P. (2022) · Cells · doi:10.3390/cells11203293 · Cited by 7
Combined Rifampicin and Ursodeoxycholic Acid Treatment Does Not Amplify Rifampicin Effects on Hepatic Detoxification and Transport Systems in Humans
Marschall, H., Wagner, M., Zollner, G., Fickert, P., Silbert, D., Gustafsson, U. O., Sahlin, S., & Trauner, M. A. (2012) · Digestion · doi:10.1159/000341420 · Cited by 7
Self-citation
Nuclear Receptor Variants in Liver Disease
Müllenbach, R., Weber, S. N., & Lammert, F. (2012) · Journal of Lipids · doi:10.1155/2012/934707 · Cited by 7
Understanding Conditional Associations between ToxCast in Vitro Readouts and the Hepatotoxicity of Compounds Using Rule-Based Methods
Mahmoud, S. Y., Svensson, F., Zoufir, A., Módos, D., Afzal, A. M., & Bender, A. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00382 · Cited by 6
A mechanistically-anchored and human stem cell-based in vitro test battery for assessing liver steatogenic potential of chemicals
Verhoeven, A., Gatzios, A., Rodrigues, R. M., Sanz-Serrano, J., Kock, J. D., Vinken, M., & Vanhaecke, T. (2025) · Toxicology · doi:10.1016/j.tox.2025.154263 · Cited by 6
Nuclear receptor 4 group A member 1 determines hepatitis C virus entry efficiency through the regulation of cellular receptor and apolipoprotein E expression
Zhu, W., Pei, R., Jin, R., Hu, X., Zhou, Y., Wang, Y., Wu, C., Lu, M., & Chen, X. (2014) · Journal of General Virology · doi:10.1099/vir.0.065003-0 · Cited by 6
Advancing care in primary biliary cholangitis: emerging insights and novel therapies
Vögelin, M., & Kremer, A. E. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2516622 · Cited by 5
Sealing the Leaky Gut Represents a Beneficial Mechanism of Zinc Intervention for Alcoholic Liver Disease
Zhong, W. H., & Zhou, Z. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814468-8.00008-9 · Cited by 5
Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity
Shores, N. J., Mendes-Corrêa, M. C., Maida, I. R., Turner, J., High, K. P., Babudieri, S., & Núñez, M. (2015) · Clinics · doi:10.6061/clinics/2015(12)05 · Cited by 5
Exploring the Hepatoprotective Effects of Naringin: A Systematic Review and Meta-Analysis of Preclinical Evidence
Fayaz, M., Viswanatha, G. L., Shylaja, H., & Nandakumar, K. (2025) · Planta Medica · doi:10.1055/a-2595-7650 · Cited by 4
Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease
Basaly, V., Bhattacharya, A., & Guo, G. L. (2024) · Molecular Pharmacology · doi:10.1016/j.molpha.2024.100014 · Cited by 4
Animal Models of Cholestasis
Fickert, P., Pollheimer, M. J., Österreicher, C. H., & Trauner, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00015-4 · Cited by 4
Self-citation
Essential role of nuclear receptors for the evaluation of the benefits of bioactive herbal extracts on liver function
Wang, F., Wu, Y., Xie, X., Sun, J., & Chen, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.012 · Cited by 4
Effects of statins on cholestasis: Good, bad or indifferent?
Kuver, R. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06836.x · Cited by 4
Liver regeneration
de Jonge, J., & Olthoff, K. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00006-6 · Cited by 4
Mechanisms of orphan nuclear receptor Nur77 in liver health, disease, and therapeutic potential: narrative review
Alsharif, O., & Rombouts, K. (2025) · npj gut and liver. · doi:10.1038/s44355-025-00037-9 · Cited by 3
Mechanism-based new approach methodologies for in vitro detection of chemical-induced liver steatosis
Verhoeven, A., Sanz-Serrano, J., & Vinken, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04235-5 · Cited by 4
Emerging role of peroxisome proliferator-activated receptor agonists in the treatment of cholestatic liver disease
Bhushan, S. R., & Kowdley, K. V. (2025) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001109 · Cited by 3
Current trends and future perspectives in the treatment of PBC and PSC: A review
Das, D. D., Sharma, N., & Chawla, P. A. (2022) · Health Sciences Review · doi:10.1016/j.hsr.2022.100065 · Cited by 4
Role of Zinc in Alcoholic Liver Disease
Zhong, W. H., Sun, Q., & Zhou, Z. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00012-4 · Cited by 3
Pharmacology of NASH
Albhaisi, S. A. M., & Sanyal, A. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00121-3 · Cited by 2
Hepatocellular Carcinoma: Epidemiology and Etiology
Degli, D., Soffritti, M., Lemoine, A., Tibaldi, E., & Manservigi, M. (2012) · InTech eBooks · doi:10.5772/30709 · Cited by 2
Cholestasis, Contraceptives, and Free Radicals
Fernández‐Martínez, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00018-7 · Cited by 2
Identification of Nuclear Receptor Targets by Chromatin Immunoprecipitation in Fatty Liver
Bécares, N., & Pineda‐Torra, I. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9130-3_14 · Cited by 2
The Liver in Metabolic Syndrome
D’Amore, S., Palasciano, G., & Moschetta, A. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_3 · Cited by 2
Vitamin B Regulation of Alcoholic Liver Disease
Halsted, C. H., & Medici, V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00008-2 · Cited by 2
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 2
Biotransformation, Elimination and Bile Acid Metabolism
Black, D. D. (2014) · Springer eBooks · doi:10.1007/978-94-017-8771-0_12 · Cited by 1
Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension
Sheng, J., Meng, Z., Li, Q., & Yang, Y. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.08.003 · Cited by 1
Current Therapeutic Strategies for Alcoholic Liver Disease
El‐Sisi, A. E., Sokar, S. S., & Mohamed, D. Z. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00002-1 · Cited by 1
Mechanisms of Bile Formation and the Pathogenesis of Cholestasis
Karpen, S. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108918978.003 · Cited by 1
Functional Development of the Liver
Suchy, F. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108918978.002 · Cited by 1
Down-regulation of DNA Methyltransferase 1 by Peroxisome Proliferator-Activated Receptor Gamma in Hepatic Stellate Cells
Li, J. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report
Scheele, J. S., Harder, J., Stanković, Z. B., Räpple, D., Dorn, A., Spangenberg, H. C., & Blum, H. E. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-478
Emerging roles for biomaterials in the treatment of liver disease
Hammond, J. S., & Lobo, D. N. (2012) · Expert Review of Medical Devices · doi:10.1586/erd.11.70
Metabolic profiles and liver steatosis in children with liver transplantation for progressive familial intrahepatic cholestasis type 1
(2020) · doi:10.5348/h06-2015-1-oa-1
Farnesol-Mediated Regulation Of Hepatic Lipid Metabolism In Heparg Cells
Pant, A. (2016) · Human Biology
Tracing the Endocytic Pathways and Trafficking Kinetics of Cell Signaling Receptors Using Single QD Nanoparticles
Fichter, K. M., & Vu, T. Q. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-336-7_22
BSEP (ABCB11)
Stieger, B., & Kullak-Ublick, G. A. (2013) · Wiley eBooks · doi:10.1002/9781118353240.ch13
The Systems Biology of Transporters – Targeting the Regulatory System for Transporters (FXR/RXR)
Gioiello, A., Marinozzi, M., Cerra, B., Custodi, C., Pellicciari, R., & Macchiarulo, A. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527679430.ch9
Characterizing a Novel Ligand for the Farnesoid X Receptor using Transgenic Zebrafish
Costa, S. (2018) · TSpace (University of Toronto)
Development of a hepatotoxicity prediction model using in vitro assay data of key molecular events
Jojima, K., Yamada, T., & Hirose, A. (2019) · Fundamental Toxicological Sciences · doi:10.2131/fts.6.327
Nuclear Receptor Signaling in the Control of Inflammation
Venteclef, N., Jakobsson, T., & Treuter, E. (2013) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_207-1
Pparγ Signaling in Hepatocarcinogenesis: Mechanistic Insights for Cellular Reprogramming and Therapeutic ImplicationsPreprint
Ishtiaq, S. M., Arshad, M. I., & Khan, J. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4192515
Additional file 2 of Dietary methionine deficiency stunts growth and increases fat deposition via suppression of fatty acids transportation and hepatic catabolism in Pekin ducks
Wu, Y., Tang, J., Wen, Z., Zhang, B., Cao, J., Zhao, L., Guo, Z., Xie, M., Zhou, Z., & Hou, S. (2022) · Figshare · doi:10.6084/m9.figshare.19785779
What Structural Biology Tells Us About the Mode of Action and Detection of Toxicants
le Maire, A., & Bourguet, W. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061724-080642
Ybx1 guides C/EBPα and cBAF chromatin-remodeling complex to promote adipogenic gene expression in steatotic hepatocytesPreprint
Jordan, J. M., Qiao, J., Zou, C., Steensels, S., Haczeyni, F., Fraim, A., Mendoza, A., de Jong, Y. P., & Ersoy, B. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.25.620017
PbsNRs: predict the potential binders and scaffolds for nuclear receptors
Zheng, G., Wu, D., Wei, X., Xu, D., Mao, T., Yan, D., Han, W., Shang, X., Chen, Z., Qiu, J., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae710
PPAR-Agonisten - etablierte Substanzen und neue Entwicklungen
Herta, T., & Tacke, F. (2025) · Gastro-News · doi:10.1007/s15036-025-3896-8
Nuclear Receptor Signaling in the Control of Inflammation
Venteclef, N., Jakobsson, T., & Treuter, E. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_207
Additional file 1 of Dietary methionine deficiency stunts growth and increases fat deposition via suppression of fatty acids transportation and hepatic catabolism in Pekin ducks
Wu, Y., Tang, J., Wen, Z., Zhang, B., Cao, J., Zhao, L., ZhanBao, G., Xie, M., Zhou, Z., & Hou, S. (2022) · Figshare · doi:10.6084/m9.figshare.19785776
Additional file 1 of Farnesoid X receptor via Notch1 directs asymmetric cell division of Sox9+ cells to prevent the development of liver cancer in a mouse model
Chen, M., Lu, C., Lu, H., Zhang, J., Qin, D., Liu, S., Li, X., & Zhang, L. (2021) · Figshare · doi:10.6084/m9.figshare.14404369
Additional file 3 of Dietary methionine deficiency stunts growth and increases fat deposition via suppression of fatty acids transportation and hepatic catabolism in Pekin ducks
Wu, Y., Tang, J., Wen, Z., Zhang, B., Cao, J., Zhao, L., ZhanBao, G., Xie, M., Zhou, Z., & Hou, S. (2022) · Figshare · doi:10.6084/m9.figshare.19785782
Additional file 1 of Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Liu, Q., Xu, L., Wu, M., Zhou, Y., Yang, J., Huang, C., Xu, T., Li, J., & Zhang, L. (2021) · Figshare · doi:10.6084/m9.figshare.14954648
High-resolution map of chromatin accessibility - insights into the focused binding of a large number of transcription factors
Zhu, I., & Landsman, D. (2026) · Epigenetics & Chromatin · doi:10.1186/s13072-026-00665-2
Impacts métaboliques d'un mélange faiblement dosé de polluants alimentaires dans un modèle murin : effets dépendants de l'âge, du sexe et du contexte nutritionnel
Labaronne, E. (2016) · theses.fr (ABES) · doi:10.70675/cc018908zb45cz4772z9f32z5dc930e07ae5
Caractérisation des effets métaboliques d’un mélange de polluants à faibles doses dans un modèle de souris déficientes en oestrogènes
Julien, B. (2019) · theses.fr (ABES) · doi:10.70675/1bc72f02z87b4z4e1bzaf8fz0c12580ba2b4
La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708
Influence of bile acids metabolism on hepatic immunity in mice
Guinot, V. (2022) · theses.fr (ABES) · doi:10.70675/b69bb11eza30fz4874z9af2za6e31b2d5ad8
Structural conservation of peroxisome proliferator–activated receptor isoforms reveals potential of perfluorooctanesulfonic acid to disrupt mammalian and avian lipid signaling
Lenz, B. Q., Ankley, G. T., & Etterson, M. A. (2026) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgag203
Estradiol-induced disruption of CAR signaling leads to bile acid homeostasis dysregulation in a murine model of intrahepatic cholestasis of pregnancy and is reversed by CAR ligands
Bajnokova, M., Laštůvková, H., Ambrož, M., Hroch, M., Štefela, A., Hricová, J., Smutná, L., Schreiberová, J., Kučera, O., Manna, D. F., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.08.027

Authors: Wagner, M., Zollner, G., & Trauner, M.
Affiliations: Baylor College of Medicine (US)
Medical University of Graz (AT)
Medical University of Vienna (AT)
Corresponding author: Trauner, Michael
ORCID: Wagner, Martin
Zollner, Gernot
Trauner, Michael
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-03
Volume: 53
Issue: 3
Pages: 1023-1034
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1002/hep.24148
OpenAlex: W1966064283
Cited by: 260
References: 7
Citations by year: 2026: 3 · 2025: 14 · 2024: 8 · 2023: 4 · 2022: 17 · 2021: 23 · 2020: 12 · 2019: 17 · 2018: 17 · 2017: 21 · 2016: 21 · 2015: 22 · 2014: 24 · 2013: 29 · 2012: 19
FWCI: 16.23
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1645 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion)
Funders: Austrian Science Foundation and funding from the European Community's Seventh Framework Programme (P18613-B05, F3008-B05)
FLIP (FP7/2007-2013, HEALTH-F2-2009-241762)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: nuclear receptors, liver disease, hepatic lipid metabolism, bile acid homeostasis, drug disposition, liver regeneration, liver fibrosis, liver inflammation, hepatic steatosis, cholestatic liver disease, drug-induced liver injury, viral hepatitis, liver cancer, transcriptional regulation
MeSH terms: Bile Acids and Salts, Cholestasis, Fatty Liver, Glucose, Hepatitis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Humans, Cholesterol, HDL, Liver, Liver Cirrhosis, Liver Diseases, Liver Regeneration, Transcription, Genetic, Triglycerides, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Chemical and Drug Induced Liver Injury, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nuclear Receptors in Liver Disease Δ

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks